THE KEMOMIND SCIENCE CONFERENCE
From Genes to Advanced Therapies:
CONNECTING HEMATOLOGY, CAR-T AND DISEASE MODELS
LJUBLJANA
25. 11. 2026
WHY DO YOU NEED TO APPLY?
Sharing knowledge
Establishing new scientific collaborations
Life Science Experts
Renowned international and Slovenian scientist in one place.
Free
Entry
We are organizing a free event for everyone.
Scientific
points
Kemomind conference has a serial cobiss publication number.
Learn about current advances in hematological genetics, molecular diagnostics and erythrocytosis research.
Discuss opportunities and bottlenecks in CAR-T and other advanced cell and gene therapies.
Discover how NAMs and advanced in vitro models can improve disease research and preclinical testing.
Meet researchers, clinicians and technology experts from across the region.
Present your work, receive expert feedback and compete for the Best Poster Award.
WHO SHOULD ATTEND?
Researchers, clinicians, laboratory specialists, PhD students, postdoctoral researchers, biotechnology and pharmaceutical professionals, and everyone working in hematology, molecular genetics, cell and gene therapy, disease modelling, organoids, 3D bioprinting, imaging and translational medicine.
From Genes to Advanced Therapies: Connecting Hematology, CAR-T and Disease Models
KEMOMIND 2026 brings together researchers, clinicians, young scientists and industry experts to explore how discoveries in hematological genetics can be translated into better diagnostics, advanced cell therapies and more relevant models of human disease.
This year’s programme connects three rapidly developing fields: erythrocytosis and hematological genetics, CAR-T and advanced cell and gene therapies, and New Approach Methodologies (NAMs), including organoids, 3D bioprinting and advanced in vitro disease models. Through invited lectures, practical case studies, a multidisciplinary round table and a poster session, KEMOMIND creates space for scientific exchange and new regional collaborations.
Participation: The official language of KEMOMIND 2026 is English. Participation is free of charge, but prior registration is required due to limited capacity.
AGENDA
...coming soon...
Wednesday, 25th of November 2026
*All lectures will be presented in the English language
Programme highlights:
-
Invited scientific lectures
-
ERY2 consortium session
-
CAR-T and advanced therapies session
-
NAMs and disease-modelling session
-
Round table: Bridging Clinical Medicine, Advanced Therapies and Disease Models
-
Poster session for students and early-career researchers
-
Best Poster Award
KEMOMIND 2026 POSTER SESSION
Are you a student, PhD candidate, postdoctoral researcher or early-career scientist working in hematology, molecular genetics, cell and gene therapy, disease modelling or translational life sciences? We invite you to present your research at the KEMOMIND 2026 Poster Session.
The poster session offers an opportunity to share your results with researchers, clinicians and industry experts from across the region, receive constructive feedback, build new collaborations and compete for the KEMOMIND 2026 Best Poster Award.
All accepted abstracts will be included in the official KEMOMIND 2026 Book of Abstracts. Posters will be evaluated by the scientific committee, and the Best Poster Award will be presented during the closing session.
Suggested topics
-
Hematological diseases, erythrocytosis and inherited genetic disorders
-
Molecular diagnostics, genomics, spatial biology and multi-omics
-
CAR-T, immune-cell therapies, genome editing and advanced therapy medicinal products
-
AAV and other technologies supporting cell and gene therapy development
-
NAMs, organoids, spheroids, 3D bioprinting and advanced in vitro models
-
Imaging, analytical methods and automation in translational research
-
Other relevant work in biomedical and life-science research
KEY DATES
Registration opens
29. September 2026
Abstract submission deadline
20. October 2026
Notification of acceptance
30. October 2026
Registration closes
17. November 2026
Conference
25. November 2026
Participation is free of charge, but prior registration is required due to limited capacity.